US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Shanghai Pharmaceuticals Holdings Company Ltd (PK) (SHPMF) 銘柄情報

Shanghai Pharmaceuticals Holdings Company Ltd (PK) (SHPMF)

1.46

0.00

( 0.00% )

更新日時： 20:18:25

Shanghai Pharmaceuticals Holdings Company Ltd (PK) (SHPMF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.46

( - )

買値

1.40

売値

1.57

出来高

-

0.00 日の範囲 0.00

1.46 52 週間の範囲 1.53

時価総額

前日終値

1.46

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 9,620,665

発行済株式数

3,708,361,809

配当利回り

0.47 (2.89%)

PER

10.31

1 株当たり利益 (EPS)

1.56

歳入

288.08B

純利益

5.81B

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological d... Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China. 詳細を表示

セクター

Healthcare

業界

Medical Distributors

ウェブサイト

www.sphchina.com

本社

Shanghai, China

設立

1994

Shanghai Pharmaceuticals Holdings Company Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker SHPMF. The last closing price for Shanghai Pharmaceuticals (PK) was US$1.46. Over the last year, Shanghai Pharmaceuticals (PK) shares have traded in a share price range of US$ 1.46 to US$ 1.53.

Shanghai Pharmaceuticals (PK) currently has 3,708,361,809 shares in issue. The market capitalisation of Shanghai Pharmaceuticals (PK) is US$5.41 billion. Shanghai Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 10.31.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	1.46	1.46	1.46	0	0	CS
26	-0.07	-4.57516339869	1.53	1.53	1.46	13	1.46	CS
52	-0.07	-4.57516339869	1.53	1.53	1.46	239	1.52853311	CS
156	-0.5689	-28.0398245355	2.0289	2.0289	0.99163	9515	1.47365509	CS
260	-0.19	-11.5151515152	1.65	2.1	0.99163	7593	1.56712502	CS

SHPMF - Frequently Asked Questions (FAQ)

What is the current Shanghai Pharmaceuticals Holdings Company Ltd (PK) share price?

The current share price of Shanghai Pharmaceuticals Holdings Company Ltd (PK) is US$ 1.46

How many Shanghai Pharmaceuticals Holdings Company Ltd (PK) shares are in issue?

Shanghai Pharmaceuticals Holdings Company Ltd (PK) has 3,708,361,809 shares in issue

What is the market cap of Shanghai Pharmaceuticals Holdings Company Ltd (PK)?

The market capitalisation of Shanghai Pharmaceuticals Holdings Company Ltd (PK) is USD 5.41B

What is the 1 year trading range for Shanghai Pharmaceuticals Holdings Company Ltd (PK) share price?

Shanghai Pharmaceuticals Holdings Company Ltd (PK) has traded in the range of US$ 1.46 to US$ 1.53 during the past year

What is the PE ratio of Shanghai Pharmaceuticals Holdings Company Ltd (PK)?

The price to earnings ratio of Shanghai Pharmaceuticals Holdings Company Ltd (PK) is 10.31

What is the cash to sales ratio of Shanghai Pharmaceuticals Holdings Company Ltd (PK)?

The cash to sales ratio of Shanghai Pharmaceuticals Holdings Company Ltd (PK) is 0.19

What is the registered address of Shanghai Pharmaceuticals Holdings Company Ltd (PK)?

The registered address for Shanghai Pharmaceuticals Holdings Company Ltd (PK) is Shanghai Pharmaceutical Building, Shanghai, 200020

What is the Shanghai Pharmaceuticals Holdings Company Ltd (PK) website address?

The website address for Shanghai Pharmaceuticals Holdings Company Ltd (PK) is www.sphchina.com

Which industry sector does Shanghai Pharmaceuticals Holdings Company Ltd (PK) operate in?

Shanghai Pharmaceuticals Holdings Company Ltd (PK) operates in the Medical Distributors sector

fredscott36

fredscott36 2分前

.....bobbie.......?????...............

theRupertPupkin

theRupertPupkin 2分前

Posted on behalf of West Red Lake Gold Mines Ltd. — WRLG.v; WRLGF

Following the release of an updated resource estimate for the Rowan Project and a maiden resource for Mount Jamie, West Red Lake Gold’s VP of Exploration, Will Robinson, further broke down the details of the announcemen

Slojab

That's no longer the case.

Currently the outstanding share count is 7,536,382,467

As of their last 10-K, Emil had 2,687,372,776 shares which is 41.3% of the O/S.

vlispxpert

vlispxpert 3分前

oh, are those going to be ETF's?

GlitteringWanderer70

GlitteringWanderer70 4分前

Retail investors are one of these 3…
Bull..Bear..or DUMMY
We don’t need to guess which one U R!!

hardlesson

hardlesson 5分前

SHMN .0016 on the ASK. Haven't seen that since last year sometime...

PRmaniac

PRmaniac 5分前

Added about 50% to my original long position.
Cramer called it a meme stock, so that was my cue....just kidding.

Gator44

Gator44 5分前

SPCM/SPCG for those living on the edge :
https://www.bing.com/videos/search?q=living+on+the+edge+music+video&view=detail&mid=4DE2B1F71F7516287DDD4DE2B1F71F7516287DDD&churl=&ru=%2fsearch%3fq%3dliving%2bon%2bthe%2bedge%2bmusic%2bvideo%26form%3dANNTH1%26refig%3d6a2af14757484dde82ab20c68d662875%2

EisMCA2

EisMCA2 5分前

Great article/interview. Thanks Fiber.

So many great things happening right now.
Looking forward to the next few announcements as we continue scaling up. Our recent production cycle effectively doubled the previous harvest to 2.5 metric tons. in a single run If we maintain this

manibiotech

manibiotech 5分前

I believe you can still sue the company and individual as a private citizen who managed the finances and operations

DeadCellShadix

DeadCellShadix 6分前

Took me some SBFM

vlispxpert

vlispxpert 6分前

joe botts

joe botts 6分前

Porch Honkey

Porch Honkey 7分前

That’s not what the incoming data shows, lol.

MysticSphinx18

MysticSphinx18 7分前

Here's what I got from Chatgpt about our chances

My Estimated Scenarios

These aren't predictions—just probability-weighted possibilities.

Scenario Probability Outcome
Business fails or continues diluting 45% 0–1×
Company survives but stagnat

getmoreshares

getmoreshares 7分前

not everyone has all there shares in a ROTH-- THINK

tzan24

Watch the video presentation

Myth

Uncommon Man - Simon McBride ( Deep Purple ) live

https://www.youtube.com/watch?v=slRC423yHtc

Brodey79

Brodey79 8分前

That’s awesome I like it.

BlazingStocks

BlazingStocks 8分前

$BURU - SunCubes recently announced the award of the DEEP LIGHT project. The project has been recognized and supported by the Italian Navy through the Polo Nazionale della Dimensione Subacquea (“PNS”) as a strategic initiative for the development of national underwater technological capabilities.htt

joe botts

joe botts 8分前

No one
Is shorting this scam.

splintered sunlight

splintered sunlight 9分前

Looking forward PC!!!!!!!!!!

Porch Honkey

Porch Honkey 9分前

Makes one wonder how 83 percent can be shorted with no bid, lol.

worthylion

worthylion 9分前

The Iran war is escalating and oil is basically flat. Really don't get it.

Shanghai Pharmaceuticals (PK)

Ares Management

Mitsu Hc Cap.24

Agf Elements Balanced Po...

Agf Global Select Fund M...

Johnson Controls

Ucore Rare Metals

Leverage Shares 2x Netfl...

iShares US Medical Devic...

1.875% to 15/02/2041 ish...

Lyxor Ftse Epra/nareit G...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。